Cohort profile: The National Colorectal Cancer Cohort (NCRCC) study in China

Purpose The National Colorectal Cancer Cohort (NCRCC) study aims to specifically assess risk factors and biomarkers related to endpoints across the colorectal cancer continuum from the aetiology through survivorship.Participants The NCRCC study includes the Colorectal Cancer Screening Cohort (CRCSC)...

Full description

Saved in:
Bibliographic Details
Main Authors: Kun Chen, Meilin Wang, Qian Xiao, Xifeng Wu, Shu Zheng, Zhizhong Pan, Jiaqi Chen, Zhaoxu Zheng, Yingshuang Zhu, Yeting Hu, Xiangxing Kong, Ye Wei, Wang Ziqiang, Da Wang, Kefeng Ding
Format: Article
Language:English
Published: BMJ Publishing Group 2021-12-01
Series:BMJ Open
Online Access:https://bmjopen.bmj.com/content/11/12/e051397.full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850170201456246784
author Kun Chen
Meilin Wang
Qian Xiao
Xifeng Wu
Shu Zheng
Zhizhong Pan
Jiaqi Chen
Zhaoxu Zheng
Yingshuang Zhu
Yeting Hu
Xiangxing Kong
Ye Wei
Wang Ziqiang
Da Wang
Kefeng Ding
author_facet Kun Chen
Meilin Wang
Qian Xiao
Xifeng Wu
Shu Zheng
Zhizhong Pan
Jiaqi Chen
Zhaoxu Zheng
Yingshuang Zhu
Yeting Hu
Xiangxing Kong
Ye Wei
Wang Ziqiang
Da Wang
Kefeng Ding
author_sort Kun Chen
collection DOAJ
description Purpose The National Colorectal Cancer Cohort (NCRCC) study aims to specifically assess risk factors and biomarkers related to endpoints across the colorectal cancer continuum from the aetiology through survivorship.Participants The NCRCC study includes the Colorectal Cancer Screening Cohort (CRCSC), which recruited individuals who were at high risk of CRC between 2016 and 2020 and Colorectal Cancer Patients Cohort (CRCPC), which recruited newly diagnosed patients with CRC between 2015 and 2020. Data collection was based on questionnaires and abstraction from electronic medical record. Items included demographic and lifestyle factors, clinical information, survivorship endpoints and other information. Multiple biospecimens including blood, tissue and urine samples were collected. Participants in CRCSC were followed by a combination of periodic survey every 5 years and annual linkage with regional or national cancer and death registries for at least 10 years. In CRCPC, follow-up was conducted with both active and passive approaches at 6, 12, 18, 24, 36, 48 and 60 months after surgery.Findings to date A total of 19 377 participants and 15 551 patients with CRC were recruited in CRCSC and in CRCPC, respectively. In CRCSC, 48.0% were men, and the average age of participants at enrolment was 58.7±8.3 years. In CRCPC, 61.4% were men, and the average age was 60.3±12.3 years with 18.9% of participants under 50 years of age.Future plans Longitudinal data and biospecimens will continue to be collected. Based on the cohorts, several studies to assess risk factors and biomarkers for CRC or its survivorship will be conducted, ultimately providing research evidence from Chinese population and optimising evidence-based guidelines across the CRC continuum.
format Article
id doaj-art-2be1502b9d2845dda6218e9bf121ca6f
institution OA Journals
issn 2044-6055
language English
publishDate 2021-12-01
publisher BMJ Publishing Group
record_format Article
series BMJ Open
spelling doaj-art-2be1502b9d2845dda6218e9bf121ca6f2025-08-20T02:20:32ZengBMJ Publishing GroupBMJ Open2044-60552021-12-01111210.1136/bmjopen-2021-051397Cohort profile: The National Colorectal Cancer Cohort (NCRCC) study in ChinaKun Chen0Meilin Wang1Qian Xiao2Xifeng Wu3Shu Zheng4Zhizhong Pan5Jiaqi Chen6Zhaoxu Zheng7Yingshuang Zhu8Yeting Hu9Xiangxing Kong10Ye Wei11Wang Ziqiang12Da Wang13Kefeng Ding141 Institute of Dermatology, Jiangsu Key Laboratory of Molecular Biology for Skin Diseases and STIs, Chinese Academy of Medical Sciences and Peking Union Medical College, Nanjing, China2 Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Cancer Medicine, Nanjing Medical University, Nanjing, China1 Mental Health Center, Xiangya Hospital, Central South University, Changsha, Hunan, China32 Department of Epidemiology, University of Texas MD Anderson Cancer Center, Houston, Texas, USADepartment of Colorectal Surgery and Oncology, Key Laboratory of Cancer Prevention and Intervention, Ministry of Education, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, ChinaDepartment of Colorectal Surgery, Sun Yat-sen University Cancer Center, Guangzhou, China1 Department of Maternal and Child Health, School of Public Health, Sun Yat-Sen University, Guangzhou, ChinaNeurosurgery Center, Beijing Tiantan Hospital, Capital Medical University, Beijing, ChinaDepartment of Colorectal Surgery and Oncology, Zhejiang University School of Medicine Second Affiliated Hospital, Hangzhou, Zhejiang, ChinaDepartment of Colorectal Surgery and Oncology, Key Laboratory of Cancer Prevention and Intervention, Ministry of Education, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, ChinaDepartment of Colorectal Surgery and Oncology, Key Laboratory of Cancer Prevention and Intervention, Ministry of Education, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, ChinaDepartment of General Surgery, Zhongshan Hospital Fudan University, Shanghai, ChinaDepartments of 1Gastrointestinal Surgery and 2Pathology, West China Hospital, Sichuan University, Chengdu, ChinaDepartment of Colorectal Surgery and Oncology, Key Laboratory of Cancer Prevention and Intervention, Ministry of Education, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, ChinaDepartment of Colorectal Surgery and Oncology, Zhejiang University School of Medicine Second Affiliated Hospital, Hangzhou, Zhejiang, ChinaPurpose The National Colorectal Cancer Cohort (NCRCC) study aims to specifically assess risk factors and biomarkers related to endpoints across the colorectal cancer continuum from the aetiology through survivorship.Participants The NCRCC study includes the Colorectal Cancer Screening Cohort (CRCSC), which recruited individuals who were at high risk of CRC between 2016 and 2020 and Colorectal Cancer Patients Cohort (CRCPC), which recruited newly diagnosed patients with CRC between 2015 and 2020. Data collection was based on questionnaires and abstraction from electronic medical record. Items included demographic and lifestyle factors, clinical information, survivorship endpoints and other information. Multiple biospecimens including blood, tissue and urine samples were collected. Participants in CRCSC were followed by a combination of periodic survey every 5 years and annual linkage with regional or national cancer and death registries for at least 10 years. In CRCPC, follow-up was conducted with both active and passive approaches at 6, 12, 18, 24, 36, 48 and 60 months after surgery.Findings to date A total of 19 377 participants and 15 551 patients with CRC were recruited in CRCSC and in CRCPC, respectively. In CRCSC, 48.0% were men, and the average age of participants at enrolment was 58.7±8.3 years. In CRCPC, 61.4% were men, and the average age was 60.3±12.3 years with 18.9% of participants under 50 years of age.Future plans Longitudinal data and biospecimens will continue to be collected. Based on the cohorts, several studies to assess risk factors and biomarkers for CRC or its survivorship will be conducted, ultimately providing research evidence from Chinese population and optimising evidence-based guidelines across the CRC continuum.https://bmjopen.bmj.com/content/11/12/e051397.full
spellingShingle Kun Chen
Meilin Wang
Qian Xiao
Xifeng Wu
Shu Zheng
Zhizhong Pan
Jiaqi Chen
Zhaoxu Zheng
Yingshuang Zhu
Yeting Hu
Xiangxing Kong
Ye Wei
Wang Ziqiang
Da Wang
Kefeng Ding
Cohort profile: The National Colorectal Cancer Cohort (NCRCC) study in China
BMJ Open
title Cohort profile: The National Colorectal Cancer Cohort (NCRCC) study in China
title_full Cohort profile: The National Colorectal Cancer Cohort (NCRCC) study in China
title_fullStr Cohort profile: The National Colorectal Cancer Cohort (NCRCC) study in China
title_full_unstemmed Cohort profile: The National Colorectal Cancer Cohort (NCRCC) study in China
title_short Cohort profile: The National Colorectal Cancer Cohort (NCRCC) study in China
title_sort cohort profile the national colorectal cancer cohort ncrcc study in china
url https://bmjopen.bmj.com/content/11/12/e051397.full
work_keys_str_mv AT kunchen cohortprofilethenationalcolorectalcancercohortncrccstudyinchina
AT meilinwang cohortprofilethenationalcolorectalcancercohortncrccstudyinchina
AT qianxiao cohortprofilethenationalcolorectalcancercohortncrccstudyinchina
AT xifengwu cohortprofilethenationalcolorectalcancercohortncrccstudyinchina
AT shuzheng cohortprofilethenationalcolorectalcancercohortncrccstudyinchina
AT zhizhongpan cohortprofilethenationalcolorectalcancercohortncrccstudyinchina
AT jiaqichen cohortprofilethenationalcolorectalcancercohortncrccstudyinchina
AT zhaoxuzheng cohortprofilethenationalcolorectalcancercohortncrccstudyinchina
AT yingshuangzhu cohortprofilethenationalcolorectalcancercohortncrccstudyinchina
AT yetinghu cohortprofilethenationalcolorectalcancercohortncrccstudyinchina
AT xiangxingkong cohortprofilethenationalcolorectalcancercohortncrccstudyinchina
AT yewei cohortprofilethenationalcolorectalcancercohortncrccstudyinchina
AT wangziqiang cohortprofilethenationalcolorectalcancercohortncrccstudyinchina
AT dawang cohortprofilethenationalcolorectalcancercohortncrccstudyinchina
AT kefengding cohortprofilethenationalcolorectalcancercohortncrccstudyinchina